XIENCE V® Everolimus Eluting Coronary Stent System India Post-marketing Single-arm Study

Mise à jour : Il y a 4 ans
Référence : NCT00631228

Femme et Homme

  • | Pays :
  • -
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

XIENCE V® India is a prospective, open-label, multi-center, observational, single-arm study to evaluate XIENCE V® EECSS continued safety and effectiveness during commercial use in real world settings.


Critère d'inclusion

  • Coronary Disease,Coronary (artery) disease,Coronary Restenosis

Liens